Skip to content

Clinical trials

Glomerulonephritis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis Country / region: United States Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20071
20081
20091
20101
20111
20121
20151
20171
20181
20192
20203
20214
20221
20233
20241
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting7
Terminated6
Active, not recruiting3
Unknown status2
Not yet recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Goldfinch Bio, Inc.3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
National Institute of Allergy and Infectious Diseases (NIAID)2
Albany Medical College1
Alexion Pharmaceuticals, Inc.1
All Natural Medicine Clinic, LLC1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Biohaven Therapeutics Ltd.1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis35
Kidney Diseases19
Glomerulonephritis, IGA13
Nephritis10
Proteinuria10
Renal Insufficiency, Chronic9
Urologic Diseases9
Autoimmune Diseases7
Lupus Nephritis7
Immune System Diseases5

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.